Cite
HARVARD Citation
Koudonas, A. et al. (2022). Methylation of PCDH17 and NEFH as prognostic biomarker for nonmetastatic RCC: A cohort study. Medicine. 101 (28), pp. e29599-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Koudonas, A. et al. (2022). Methylation of PCDH17 and NEFH as prognostic biomarker for nonmetastatic RCC: A cohort study. Medicine. 101 (28), pp. e29599-. [Online].